Drug Patent List
First Filer Exclusivity TimelineNew
Newsletter
Weekly Digest

Pharsight

Jiangsu Hansoh Drug Patent Portfolio

Jiangsu Hansoh's Family Patents


Family Patents



Recent FDA approvals and tentative approvals for Jiangsu Hansoh

This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.


Generic drugs

Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.

Drug Name Submission class (FDA) Submission Category Submission Date
Dapagliflozin ORIG-1
ⓘ
Orig = Original submission
Suppl = Supplement submission
Number = submission sequence
- 02 Apr, 2026


Clinical Trials

Recent Clinical Trials by Jiangsu Hansoh:

Title Lead Sponsor Collaborators Status Phases
Clinical Trials
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC Jiangsu Hansoh Pharmaceutical Co., Ltd. NA NOT YET RECRUITING
(Aug 1, 2026)
PHASE3
A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504 Jiangsu Hansoh Pharmaceutical Co., Ltd. NA NOT YET RECRUITING
(Aug 1, 2026)
PHASE1
A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504 Jiangsu Hansoh Pharmaceutical Co., Ltd. NA NOT YET RECRUITING
(Aug 1, 2026)
PHASE1
An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. NA NOT YET RECRUITING
(Jun 1, 2026)
PHASE1
A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia Jiangsu Hansoh Pharmaceutical Co., Ltd. NA COMPLETED
(Apr 1, 2026)
PHASE2
A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease Jiangsu Hansoh Pharmaceutical Co., Ltd. NA NOT YET RECRUITING
(Apr 1, 2026)
PHASE2


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List